PEBC - Programa de Epigenética y Biología del Cáncer 

Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont

Catalonia's Parliament awards its medal of honor to Dr. Manel Esteller

Manel Esteller receives the National Research Prize 2015



PEBC update




The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation set up on 16th June 2004 as a separate legal entity resulting from a change in name of the former August Pi i Sunyer (FAPS) Foundation, set up in 1988. IDIBELL has scientific cooperation agreements with the following institutions/centres:

- University of Barcelona (UB) and its science park
- Bellvitge University Hospital (HUB)

- Catalan Institute of Oncology (ICO)

- Institute for Imaging Diagnosis (IDI)

- Transfusion Centre and Tissue Bank (CTBT)

It is a great pleasure to announce the launching in 2008 of a new research program devoted to basic research within IDIBELL, The Cancer Epigenetics and Biology Program (PEBC).

.>> more info


PNAS, Proceedings of the National Academy of Sciences - Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer >>


Cancer Research - RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation >>


The Lancet Oncology - Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis >>













Generalitat de Catalunya Institut d'Investigacio Biomedica de Bellvitge ICREA Sixth Framework Programme Seventh Framework Programme ERC Ministerio de Sanidad y Consumo Ministerio de Educación y Ciencia

© 2008® | PEBC | Todos los derechos reservados |  WEBMAIL  |  INTRANET  |  FTP